干燥综合征患者神经症状负担的国际调查
该国际调查由患者研究伙伴与风湿免疫科医生共同设计,覆盖60个国家4050例干燥综合征患者。结果显示,所有应答者均报告至少一种神经症状,且至少半数患者症状为中重度影响;仅21.6%获神经科正式诊断,其中仅21%接受药物治疗、23%报告显著改善。
要点
- 所有应答干燥综合征患者均报告至少一种神经症状,半数以上为中重度影响。
- 仅21.6%有症状患者获神经科正式诊断,其中仅21%接受药物治疗。
- 接受治疗者中仅23%报告症状显著或完全改善,半数患者认为医生低估其神经症状。
核心结论
- 干燥综合征神经症状的患病率可能被低估,神经受累是重大未满足需求。
研究设计与样本
- 匿名多语言国际调查由患者研究伙伴与风湿免疫科医生共同开发,通过患者协会分发,收集60个国家4050例干燥综合征患者的有效应答。
主要发现
- 全部应答者均报告至少一种调查所列神经症状,每种症状在至少半数患者中造成中重度影响。
- 21.6%的有症状患者报告获神经科正式诊断,其中仅21%接受药物治疗。
- 接受药物治疗者中仅23%报告症状显著或完全改善,整体对神经受累诊疗满意度差。
- 半数应答者认为医疗提供者低估了其神经症状。
关键数值与推荐
- 有症状患者中获神经科正式诊断者占21.6%。
- 获诊断者中接受药物治疗者仅21%,其中报告显著或完全改善者仅23%。
临床怎么用
- 临床应提高对干燥综合征患者神经症状的识别与归因,减少漏诊并推动及时诊断。
- 对已诊断神经受累者,现有药物治疗应答有限,需探索更有效治疗策略。
局限性
- 研究为匿名问卷调查,诊断与治疗信息基于患者自报,可能存在回忆偏倚与报告偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Neurological involvement in Sjögren's disease (neuro-SjD), reported by up to 20% of patients, represents a highly relevant extra-glandular manifestation. Owing to the clinical complexity, frequent diagnostic delay and the poor response to treatment, neuro-SjD remains a major unmet need. This study aimed to better understand the burden of neuro-SjD from the patient perspective, focusing on the overall care journey. METHODS: An anonymous multilingual survey was co-developed by patient research partners and rheumatologists and distributed via patient associations. RESULTS: A total of 4050 valid responses from SjD patients across 60 countries were collected and analysed. All respondents reported at least one of the symptoms listed in the survey, with each symptom having a medium-to-severe impact in at least half of the patients. A formal diagnosis of neuro-SjD most often made by a neurologist was reported by 21.6% of symptomatic patients. Among those diagnosed, only 21% received pharmacological therapies and just 23% of them reported significant or complete symptom improvement. Overall, satisfaction with neuro-SjD care was poor, with half of the respondents feeling that healthcare providers underestimated their neurological symptoms. CONCLUSION: Our findings suggest that the prevalence of neurological symptoms in SjD is likely underestimated and highlight neuro-SjD as a major unmet need. We advocate for raising awareness and prompting research in this area, facilitating the diagnosis and correct attribution of these debilitating manifestations to support timely diagnosis, accurate symptom attribution and ultimately identifying effective treatment strategies to improve the quality of life of people living with SjD.
引用
- Alunno A, Mariani FM, Ritschl V, et al. The burden and profile of neurological symptoms in patients with Sjögren disease: results from an international survey. Rheumatology (Oxford). 2026. PMID: 41734285. doi:10.1093/rheumatology/keag102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。